CD4 T follicular helper cells in HIV

  • 11k

    Total downloads

  • 47k

    Total views and downloads

Submit your idea

You will be redirected to our submission process.

Submit your manuscript summarySubmit your manuscript

About this Research Topic

Submission closed

Background

Jointly discovered by Bernhard Moser and Martin Lipp in 2000, “follicular B helper T cells” or T follicular helper cells (TFH) revolutionized the field of T cell immunology by challenging the binary TH1/TH2 paradigm of helper T cell identity. The subsequent identification of B cell lymphoma (Bcl)-6 as the transcriptional architect of TFH cell fate led to their formal recognition as a distinct helper T cell subset. TFH cells interact dynamically with germinal center (GC) B cells and foster proliferation and survival of B cells within the GC on the basis of high affinity for antigen. Cognate help from TFH cells is vital for GC reactions and drives the establishment of long-lived humoral immunity. This specialized function of TFH cells makes them highly significant in HIV where vaccine-mediated induction of broadly neutralizing and persistent antibody is the major goal of current HIV vaccine strategies. There are several gaps in our knowledge of TFH cell biology that need to be addressed in order to optimally harness TFH cell help to advance HIV vaccine design and to improve infection outcomes. The goal of “CD4 TFH cells in HIV” is to provide a platform to explore and communicate these rapidly evolving and highly integrated issues central to our understanding of TFH cells in HIV. We encourage reviews, perspectives, and the discussion of new concepts, hypotheses, and conflicting viewpoints. We welcome submissions on the following topics:

(1) TFH cells in peripheral blood: surrogate for GC reactions? Following vaccination or infection, activated CXCR5+ CD4 T cells transiently accumulate in peripheral blood. Are these blood effector TFH cells reliable indicators of ongoing germinal center responses in complex systems? This is an important question in humans and in rhesus macaque models of HIV where lymph node sampling is not feasible. Understanding the significance of blood TFH cells and developing assays to quantitate vaccine-specific TFH cells in blood during effector and memory time points will spearhead their utility as biomarkers of vaccine efficacy.

(2) Mucosal TFH cells: friend or foe? Generation of potent and durable antibody at the mucosal frontlines is crucial for an effective HIV vaccine. However, the TFH cell response to vaccination and infection within the mucosa is poorly understood. What is the role of vaccine-elicited TFH cells in the development of mucosal antibody? On the other hand, vaccine-elicited mucosal TFH cells may serve as targets for viral entry and thereby subvert vaccine efficacy. The development of an effective HIV vaccine will require the precise understanding of cues driving mucosal TFH cell responses their roles in vaccine efficacy.

(3) Magnitude of TFH cell response: can there be too much of a good thing? While there is strong interest in the induction of robust TFH cell responses to vaccination, there is little experimental evidence demonstrating that higher magnitude TFH cell response induces higher affinity antibody. Because selective TFH cell help forms the basis of selection and survival of high affinity B cells within the GC, could abundance of TFH cell help compromise generation of high affinity antibody?

(4) T follicular regulatory cells: important parameter of vaccine efficacy? Follicular regulatory cells (TFR) are a newly defined subset of TFH cells that suppress humoral immunity. A better understanding of their roles in vaccine-elicited humoral immune response and whether inhibiting TFR represents a strategy to enhance vaccine efficacy is a key issue in HIV vaccine design.

(5) Memory TFH cells: determinant of the efficacy of booster immunizations? Repeated vaccination in the form of prime-boost immunizations is critical in establishing strong cellular and humoral immunity against HIV. Therefore, understanding the factors facilitating the induction of memory TFH cells, and delineating how the magnitude and phenotype of vaccine-elicited memory TFH cells drives potency of the antibody recall response is critical. Equally important is understanding whether vaccine-induced memory TFH cells provide a fertile target for viral entry and replication upon HIV exposure.


(6) Role of TFH cells in acute HIV infection: mechanisms of permissivity to HIV and consequences for bNab development What are the cell-intrinsic mechanisms driving HIV entry and replication within GC TFH cells, and does their residence within GCs, typically restricted from cytolytic CD8 T cell influx, foster establishment of viral reservoirs? Importantly, how does viral replication in TFH cells impact their ability to provide B cell help and induce bNAbs? These issues lie at the crux of deciphering the role of TFH cells in HIV infection.

(7) Role of TFH cells in chronic HIV infection: how does antigen persistence influence the GC response? During natural infection, in some infected individuals, broadly neutralizing antibodies that have acquired extensive hypermutation and even deletion/insertion mutations do not appear until several years following initial infection. Does the duration/persistence of the TFH response influence the selection process of these unusual antibodies over long-periods of time? How do the phenotype, function, and transcriptional signature of “persistent” TFH cells differ from that of effector and memory TFH cells? Do these cells persist under anti-retroviral therapy or in chronic asymptomatic HIV infection?

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Topic editors

Frequently asked questions

  • Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

    Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

  • The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

    Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

  • As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

    A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

  • Each Research Topic must be approved by the specialty chief editor, and it falls under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

    In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

  • Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

    As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

    Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

     

  • Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

    Check available article types here 

  • Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

    Suggest your topic here 

  • A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

    The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

  • As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

     

    You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

  • As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

  • If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

  • Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

  • Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

  • As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

    Find out more about our Research Topics

  • Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

    Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

  • In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.

     

Participating Journals

Impact

  • 47kTopic views
  • 32kArticle views
  • 11kArticle downloads
View impact